PUBLIC COMPANY
save$IRWDIRONWOOD PHARMACEUTICALS INC
$IRWD3.5000+1.16%Boston, MA, USupdated 14d ago
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Sanofi-backed Windward hits $225M IPO goal, as Rezera delays listing over ‘market conditions’Windward Bio’s IPO has blown to exactly the spot the Swiss biotech had been aiming for, bringing in $225 million to fund a pair of respiratory drugs licensed from China.fiercebiotech · 5d ago
- Sanofi-backed Windward breezes toward $204M IPO to fund respiratory pipeline from ChinaWindward Bio is sailing toward the public markets with the aim of raising over $200 million in proceeds to fund two respiratory drugs licensed from China.fiercebiotech · 9d ago
- Chutes & Ladders—Troubled CSL enlists GSK vet Deborah Waterhouse to leadCSL has tapped a new leader to steer it through a make-or-break period. Ironwood's CEO since 2021 is hanging up his hat. CytoDyn's new helmsman is highlighting the company's "transformational perio…fiercebiotech · 27d ago
- Chutes & Ladders—Cue lines up new CMO and research headCue Biopharma is tapping in a new chief medical officer and head of R&D in Dominic Borie, M.D., Ph.D., a physician-scientist with over two decades of industry experience.fiercebiotech · 4mo ago
Data sources
last refreshed 15m ago
Found something off?
comments(0)
5-min edit window · permanent after that